Elevated Blood Pressure in the Acute Phase of Stroke and the Role of Angiotensin Receptor Blockers

Table 1

Included trials.

Study	Year	Study design	Antihypertensive agent
Acute Candesartan Cilexetil Therapy in Stroke Survivors (ACCESS) [27]	2003	Prospective, double-blind, placebo-controlled, randomized, multicenter phase II study.	Candesartan cilexitil
Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) [28]*	2008	Prospective, double-blind, placebo-controlled, randomized, multicenter phase III study.	Telmisartan
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST) [29]	2011	Prospective, double-blind, placebo-controlled, randomized, multicenter phase III study.	Candesartan cilexitil

∗In the PRoFESS trial a subgroup analysis has been considered.